欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Apoptosis-MDM2-p53-PG3-Oc
PG3-Oc

Chemical Structure : PG3-Oc

CAS No.: 2137475-72-8

PG3-Oc (p53 activator, ATF4 activator PG3-Oc)

货号: PC-23284Not For Human Use, Lab Use Only.

PG3-Oc is a small-molecule that restores p53 pathway-signaling in tumor cells with mutant-p53, activates ATF4 and upregulates p53 target genes, inhibits cell viabiltiy of p53 mutation R273H (HT29 cell) with IC50 of 31 nM.

规格 价格 库存 数量
50 mg Get quote
100 mg Get quote
250 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC)

生物&药学活性

PG3-Oc is a small-molecule that restores p53 pathway-signaling in tumor cells with mutant-p53, activates ATF4 and upregulates p53 target genes, inhibits cell viabiltiy of p53 mutation R273H (HT29 cell) with IC50 of 31 nM.
PG3-Oc inhibits cell proliferation and induces apoptosis in mutant p53-expressing cancer cell lines with IC50 values within the nano-molar range.
PG3-Oc has a 4- to 9-fold therapeutic index in colorectal cancer cell lines as compared to normal colon cells CCD 841 Con.
PG3-Oc treatment induces caspase-8 and caspase-3 activation in CRC cell lines, and caspase activation is required for PG3-Oc-induced cell death.
PG3-Oc partially restores the p53 pathway globally.
PUMA is required for PG3-Oc-mediated cell death, induces significant downregulation of MYC and upregulation of PUMA protein levels in a panel of p53 mutant cell lines, such as HT29, DLD1, FaDu, MDA-MB-231, and MDA-MB-468. SW480 and CAL27.
PG3-Oc induces upregulation of ATF4, ATF4 is a mediator of PG3-Oc-induced p53 pathway restoration.
PG3-Oc (5 mg/kg, times weekly for 2 wk) inhibits tumor growth in the HT29 mouse xenograft model.

物理化学性质&存储条件

分子量 451.61
分子式 C27H37N3O3
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

octyl (Z)-3-(5-((4'-methoxy-1H,5'H-[2,2'-bipyrrol]-5'-ylidene)methyl)-2,4-dimethyl-1H-pyrrol-3-yl)propanoate

参考文献

1. Xiaobing Tian, et al. Oncotarget. 2024 Sep 17:15:614-633.

2. Tian X, et al. Neoplasia. 2021 Mar;23(3):304-325.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: